Vice President, Business Development
As Vice President, Business Development, Jeannie Joughin is responsible for managing CSL Behring’s current business licensing arrangements and relationships as well as building the business for tomorrow. Based in King of Prussia, Dr. Joughin liaises closely with CSL Behring’s Commercial Development Team in the US, Germany and Switzerland.
Dr. Joughin began her career in the pharmaceutical industry in 1992 as a Clinical Research Manager with Bristol-Myers Squibb. After managing local trials in oncology and cardiology, she moved into New Product Commercialisation as the interface between the medical and marketing departments. From there, Dr. Joughin worked in Brand Management. After successfully completing several marketing roles in the National Stroke Foundation, MediMark International and Mayne Pharma, Dr. Joughin joined CSL Biotherapies in 2005 as Director, Pharmaceuticals Marketing and In-licensing. She assumed responsibility for a portfolio of pharmaceutical products from several licensing partners in various therapeutic areas. Her responsibilities included extending distribution agreements with current partners when appropriate and securing various new product distribution agreements.
Dr. Joughin has also held various scientific positions including Senior Research Scientist, Post-Doctorate and Senior Post-Doctorate positions in Australia at The Alfred Hospital, The Walter & Eliza Hall Institute, as well as internationally in Austria (University Clinic, Innsbruck) and Switzerland (Ludwig Institute for Cancer Research, Lausanne).
Dr. Joughin holds a Bachelor’s degree (Honours) and PhD (Immunology) from Australia’s Monash University and a diploma in marketing from Melbourne University.
Return to Top